Linjun Cai1, Jenny Rubin, Wenyu Han, Per Venge, Shengyuan Xu. 1. Department of Preventive Veterinary Medicine, Molecular Immunology and Pathogenic Microorganism, Jilin University, Changchun, People's Republic of China.
Abstract
BACKGROUND AND OBJECTIVES: Several molecular forms of human neutrophil lipocalin/neutrophil gelatinase-associated lipocalin (HNL/NGAL), a novel biomarker for acute kidney injury (AKI), have been found in urine. The origin of these different forms and the effect of antibody configuration on assay performances were investigated in this report. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The molecular forms of HNL/NGAL from human neutrophils and present in urine obtained from cardiac surgery patients and patients with urinary tract infection (UTI), as well as secreted from HK-2 cells, were studied by Western blotting. The levels of HNL/NGAL in urine were measured by ELISAs. Kidney injury was simulated by incubation of HK-2 cells under stressful conditions. RESULTS: The major molecular form of HNL/NGAL secreted by neutrophils is dimeric, whereas the major form secreted by HK-2 cells is monomeric. This was reflected by a predominance of the monomeric form in urine from patients with AKI and the dimeric form in patients with UTIs. The epitope specificities of the antibody used in the ELISAs had a profound effect on assay performance and paralleled differences of the antibodies to identify the different forms of urine HNL/NGAL. CONCLUSIONS: The monomeric form is the predominant form secreted by tubular epithelial cells, and the dimeric form is the predominant form secreted by neutrophils. The development of molecular form-specific assays for HNL/NGAL may be a means to identify the origin of HNL/NGAL in urine and construct more specific tools for the diagnosis of AKI.
BACKGROUND AND OBJECTIVES: Several molecular forms of human neutrophil lipocalin/neutrophil gelatinase-associated lipocalin (HNL/NGAL), a novel biomarker for acute kidney injury (AKI), have been found in urine. The origin of these different forms and the effect of antibody configuration on assay performances were investigated in this report. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The molecular forms of HNL/NGAL from human neutrophils and present in urine obtained from cardiac surgery patients and patients with urinary tract infection (UTI), as well as secreted from HK-2 cells, were studied by Western blotting. The levels of HNL/NGAL in urine were measured by ELISAs. Kidney injury was simulated by incubation of HK-2 cells under stressful conditions. RESULTS: The major molecular form of HNL/NGAL secreted by neutrophils is dimeric, whereas the major form secreted by HK-2 cells is monomeric. This was reflected by a predominance of the monomeric form in urine from patients with AKI and the dimeric form in patients with UTIs. The epitope specificities of the antibody used in the ELISAs had a profound effect on assay performance and paralleled differences of the antibodies to identify the different forms of urine HNL/NGAL. CONCLUSIONS: The monomeric form is the predominant form secreted by tubular epithelial cells, and the dimeric form is the predominant form secreted by neutrophils. The development of molecular form-specific assays for HNL/NGAL may be a means to identify the origin of HNL/NGAL in urine and construct more specific tools for the diagnosis of AKI.
Authors: Kiyoshi Mori; H Thomas Lee; Dana Rapoport; Ian R Drexler; Kirk Foster; Jun Yang; Kai M Schmidt-Ott; Xia Chen; Jau Yi Li; Stacey Weiss; Jaya Mishra; Faisal H Cheema; Glenn Markowitz; Takayoshi Suganami; Kazutomo Sawai; Masashi Mukoyama; Cheryl Kunis; Vivette D'Agati; Prasad Devarajan; Jonathan Barasch Journal: J Clin Invest Date: 2005-03 Impact factor: 14.808
Authors: Cecilia A Fernández; Li Yan; Gwendolyn Louis; Jiang Yang; Jeffery L Kutok; Marsha A Moses Journal: Clin Cancer Res Date: 2005-08-01 Impact factor: 12.531
Authors: Kathleen D Liu; Wei Yang; Alan S Go; Amanda H Anderson; Harold I Feldman; Michael J Fischer; Jiang He; Radhakrishna R Kallem; John W Kusek; Stephen R Master; Edgar R Miller; Sylvia E Rosas; Susan Steigerwalt; Kaixiang Tao; Matthew R Weir; Chi-Yuan Hsu Journal: Am J Kidney Dis Date: 2014-10-11 Impact factor: 8.860
Authors: Elvira Parravicini; Chiara Locatelli; John M Lorenz; Sheri L Nemerofsky; David A Bateman Journal: Pediatr Res Date: 2016-07-13 Impact factor: 3.756
Authors: Roya Hassanzadeh; Daniel Lasserson; Christopher P Price; Carl Heneghan; Ann Van den Bruel; Annette Plüddemann Journal: Br J Gen Pract Date: 2016-10 Impact factor: 5.386